|
DE102013205528B3
|
|
Method of magnetic resonance with excitation by a prewinding pulse
|
|
DE102013004625A1
|
|
Bioresorbable stent
|
|
EP2769989A1
|
|
Recombinant bispecific antibody that binds to the CD133 antigen on tumor cells and to the human CD3 T cell receptor
|
|
EP2644613A1
|
|
Cell wall polymers of enterococcus faecalis and uses thereof
|
|
EP2626432A1
|
|
Method for the diagnosis of myeloid neoplasias and solid tumors and diagnostic kits
|
|
DE102011120394A1
|
|
Method and microstructure device for electrical contacting of biological cells
|
|
DE102011084867A1
|
|
MRI method and tomography device for the quantitative measurement of cerebral perfusion
|
|
EP2556832A1
|
|
Uridine and uridine analogues for use in the treatment of chronic obstructive pulmonary disease
|
|
EP2535352A1
|
|
Pharmaceutical compound with antibodies against catalase and superoxide dismutase for tumour treatment
|
|
EP2526951A1
|
|
Rhamno-polysaccharide from Enterococcus faecium clonal complex 17 and uses thereof
|
|
EP2500349A1
|
|
Synthetic LTA mimetics and use thereof as vaccine component for therapy and/or prophylaxis against gram-positive infections
|
|
EP2450053A1
|
|
Novel antigen of enterococcal pathogens and use thereof as vaccine component for therapy and/or prophylaxis
|
|
EP2399598A1
|
|
Blockade of CCL18 signaling via CCR6 as a therapeutic option in fibrotic diseases and cancer
|
|
EP1950286A1
|
|
Tri-demethylation-capable protein complex, method of its preparation and its use
|
|
DE102006053385A1
|
|
Enterococcus faecalis antigen
|
